LITE
Lumentum Holdings Inc.
Lumentum Holdings Inc. (LITE) Stock News
The latest LITE headlines and market coverage — 1 recent story, updated throughout the day.
- GlobeNewswire Inc.·
Arvinas Joins The Michael J. Fox Foundation’s LITE and PPMI Programs to Advance New Therapies Targeting LRRK2 for Parkinson’s Disease
Arvinas announced it has joined The Michael J. Fox Foundation's LRRK2 Investigative Therapeutics Exchange (LITE) program and Parkinson's Precision Medicine Initiative (PPMI) to advance ARV-102, its investigational PROTAC drug targeting LRRK2 for treating Parkinson's disease and progressive supranuclear palsy. The company plans to initiate Phase 1b and potentially Phase 2 registrational trials in PSP patients in the second half of 2026.